LLY

724.75

-2.78%↓

JNJ

153.19

-0.27%↓

ABBV

181.66

-1.71%↓

NVO

68.18

+0.09%↑

UNH

303.28

-5.72%↓

LLY

724.75

-2.78%↓

JNJ

153.19

-0.27%↓

ABBV

181.66

-1.71%↓

NVO

68.18

+0.09%↑

UNH

303.28

-5.72%↓

LLY

724.75

-2.78%↓

JNJ

153.19

-0.27%↓

ABBV

181.66

-1.71%↓

NVO

68.18

+0.09%↑

UNH

303.28

-5.72%↓

LLY

724.75

-2.78%↓

JNJ

153.19

-0.27%↓

ABBV

181.66

-1.71%↓

NVO

68.18

+0.09%↑

UNH

303.28

-5.72%↓

LLY

724.75

-2.78%↓

JNJ

153.19

-0.27%↓

ABBV

181.66

-1.71%↓

NVO

68.18

+0.09%↑

UNH

303.28

-5.72%↓

Search

IQVIA Holdings Inc

Cerrado

SectorSanidad

137.38 -5.16

Resumen

Variación precio

24h

Actual

Mínimo

137.21

Máximo

144.94

Métricas clave

By Trading Economics

Ingresos

-188M

249M

Ventas

-129M

3.8B

P/B

Media del Sector

21.3

56.602

BPA

2.7

Margen de beneficios

6.503

Empleados

89,000

EBITDA

-281M

740M

Recomendaciones

By TipRanks

Recomendaciones

Comprar

Estimación a 12 Meses

+27.77% upside

Dividendos

By Dow Jones

Próximas Ganancias

21 jul 2025

Estadísticas de Mercado

By TradingEconomics

Capitalización Mercado

-8.6B

27B

Apertura anterior

142.54

Cierre anterior

137.38

Noticias sobre sentimiento de mercado

By Acuity

50%

50%

179 / 382 Clasificación en Healthcare

Puntuación técnica

By Trading Central

Confianza

Bullish Evidence

IQVIA Holdings Inc Gráfico

Resultados pasados no son un indicador fiable de resultados futuros.

Noticias Relacionadas

20 may 2025, 20:54 UTC

Adquisiciones, fusiones, absorciones

PNC to Buy Private-Equity Agent Aqueduct Capital

20 may 2025, 20:50 UTC

Ganancias

Palo Alto Networks Posts Higher 3Q Sales, Profit Slips

20 may 2025, 23:48 UTC

Adquisiciones, fusiones, absorciones

Kraft Heinz Evaluating Strategic Transactions, Berkshire Hathaway Steps Away From Board -- Update

20 may 2025, 23:42 UTC

Charlas de Mercado

Nikkei May Trade Rangebound Amid Tariff Uncertainty -- Market Talk

20 may 2025, 23:39 UTC

Charlas de Mercado

Gold Steady, Supported by Lingering U.S. Fiscal-Deficit Concerns -- Market Talk

20 may 2025, 23:08 UTC

Charlas de Mercado

James Hardie's Repair & Remodel Outlook Surprises RBC -- Market Talk

20 may 2025, 22:46 UTC

Adquisiciones, fusiones, absorciones

Gold Road: Takeover Remains Subject to Independent Expert Findings; Shareholder, Court Approval

20 may 2025, 22:45 UTC

Adquisiciones, fusiones, absorciones

Gold Road: Notified Australia Government Has No Objections to Takeover by Gold Fields

20 may 2025, 22:44 UTC

Principales Noticias

Venezuela Frees U.S. Air Force Veteran in Overture to Trump -- 2nd Update

20 may 2025, 22:20 UTC

Principales Noticias

In Latest EV Pullback, Ford to Share Battery Plant With Nissan -- WSJ

20 may 2025, 22:00 UTC

Ganancias

ZTO Express (Cayman) 1Q Adj EPS 37c >ZTO

20 may 2025, 22:00 UTC

Ganancias

ZTO Express (Cayman) 1Q EPS 34c >ZTO

20 may 2025, 22:00 UTC

Ganancias

ZTO Express (Cayman) 1Q Rev $1.5B >ZTO

20 may 2025, 21:44 UTC

Ganancias

James Hardie Industries 4Q Adj EPS 36c >JHX

20 may 2025, 21:44 UTC

Ganancias

James Hardie Industries: Sees FY26 North America Net Sales Growth Up Low Single Digits >JHX

20 may 2025, 21:44 UTC

Ganancias

James Hardie Industries 4Q EPS 10c >JHX

20 may 2025, 21:44 UTC

Ganancias

James Hardie Industries 4Q Sales $972M >JHX

20 may 2025, 20:52 UTC

Principales Noticias

Elon Musk to Cut Back Political Spending -- 3rd Update

20 may 2025, 20:52 UTC

Charlas de Mercado

Global Forex and Fixed Income Roundup: Market Talk

20 may 2025, 20:52 UTC

Charlas de Mercado

Mexican Stocks Near Record High As Trade Concerns Ease -- Market Talk

20 may 2025, 20:30 UTC

Adquisiciones, fusiones, absorciones

PNC Financial: Aqueduct Acquisition Expected to Close in Mid-Summer, Terms Won't be Disclosed >PNC

20 may 2025, 20:28 UTC

Adquisiciones, fusiones, absorciones

PNC Bank Agrees To Acquire Aqueduct Capital Group To Complement Harris Williams Capabilities >PNC

20 may 2025, 20:23 UTC

Adquisiciones, fusiones, absorciones

Tesla CEO Musk Says He Plans to Be at White House for a Couple Days Every Few Weeks

20 may 2025, 20:22 UTC

Ganancias

XP 1Q Adj EPS BRL2.29 >XP

20 may 2025, 20:22 UTC

Ganancias

XP 1Q Rev BRL4.345B >XP

20 may 2025, 20:21 UTC

Adquisiciones, fusiones, absorciones

Tesla CEO Musk: 'We're in the Big Bang of Intelligence Explosion'

20 may 2025, 20:20 UTC

Principales Noticias

Fed's Bostic Signals Longer Delay in Cutting Interest Rates -- Barrons.com

20 may 2025, 20:19 UTC

Adquisiciones, fusiones, absorciones

Tesla CEO Musk Says He Doesn't Currently Have Plans to Merge Tesla, xAI

20 may 2025, 20:11 UTC

Principales Noticias

Venezuela Frees U.S. Air Force Veteran in Overture to Trump -- Update

20 may 2025, 20:09 UTC

Ganancias

Palo Alto Networks 3Q Remaining Performance Obligation $13.5 B >PANW

Comparación entre iguales

Cambio de precio

IQVIA Holdings Inc previsión

Precio Objetivo

By TipRanks

27.77% repunte

Estimación a 12 Meses

Media 183.4 USD  27.77%

Máximo 211 USD

Mínimo 160 USD

De acuerdo con 16 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para IQVIA Holdings Inc Dist en los últimos 3 meses.

Consenso

By TipRanks

Comprar

16 ratings

11

Comprar

5

Mantener

0

Vender

Puntuación técnica

By Trading Central

150.68 / 153.45Soporte y Resistencia

Corto Plazo

Bullish Evidence

Medio plazo

Neutral Evidence

Largo Plazo

Bearish Evidence

Sentimiento

By Acuity

179 / 382 Clasificación en Sanidad

Noticias sobre sentimiento de mercado

Neutral

Volatilidad

Por debajo de la media

Volumen de Noticias (RCV)

Por debajo de la media

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

$

Acerca de IQVIA Holdings Inc

IQVIA Holdings Inc. engages in the provision of advanced analytics, technology solutions, and clinical research services to the life sciences industry in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment offers a range of cloud-based applications and related implementation services; real world solutions that enable life sciences and provider customers to generate and disseminate evidence, which informs health care decision making and improves patients' outcomes; and strategic and implementation consulting services, such as advanced analytics and commercial processes outsourcing services. This segment also provides country level performance metrics related to sales of pharmaceutical products, prescribing trends, medical treatment, and promotional activity across various channels, including retail, hospital, and mail order; and measurement of sales or prescribing activity at the regional, zip code, and individual prescriber level. The Research & Development Solutions segment offers project management and clinical monitoring; clinical trial support; strategic planning and design services; and patient and site centric solutions, as well as central laboratory, genomic, bioanalytical, ADME, discovery, and vaccine and biomarker laboratory services. The Contract Sales & Medical Solutions segment provides health care provider and patient engagement services, and scientific strategy and medical affairs services. It serves pharmaceutical, biotechnology, device and diagnostic, and consumer health companies. The company has a collaboration with argenx SE; and a strategic collaboration with NVIDIA Corporation. The company was formerly known as Quintiles IMS Holdings, Inc. and changed its name to IQVIA Holdings Inc. in November 2017. The company is headquartered in Durham, North Carolina.